Tissue redox activity as a hallmark of carcinogenesis: From early to terminal stages of cancer

Clinical Cancer Research

Volumn 19, Issue 9, 2013, Pages 2503-2517

  Bakalova, Rumiana ^a,b   Zhelev, Zhivko ^a,c   Aoki, Ichio ^a   Saga, Tsuneo ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b UNIVERSITY OF SOFIA   (Bulgaria)

^c TRAKIA UNIVERSITY   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B;

ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; EARLY CANCER; ELECTRON SPIN RESONANCE; ENZYME BLOOD LEVEL; GLIOMA; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEUROBLASTOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TERMINAL DISEASE; TISSUE REDOX ACTIVITY; TISSUE TOTAL ANTIOXIDANT CAPACITY;

ANIMALS; ANTIOXIDANTS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CONTRAST MEDIA; GLIOMA; HALF-LIFE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; NITROGEN OXIDES; OXIDATION-REDUCTION;

EID: 84877095415     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-3726     Document Type: Article

References (46)

1. Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 2009;8:579-91.
2. Gius D, Spitz DR. Redox signaling in cancer biology. Antioxid Redox Signal 2006;8:1249-52. (Pubitemid 44182423)
3. Diaz B, Courtneidge SA. Redox signaling at invasive microdomains in cancer cells. Free Radic Biol Med 2012;52:247-56.
4. Irwin ME, Rivera-Del Valle N, Chandra J. Redox control of leukemia: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2012;8:1349-83.
5. Ziech D, Franco R, Pappa A, Panayiotidis MI. Reactive oxygen species (ROS)-induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res 2011;711:167-73.
6. Zienolddiny S, Ryberg D, Haugen A. Induction of microsatellite mutations by oxidative agents in human lung cancer cell lines. Carcinogenesis 2000;21:1521-6. (Pubitemid 30601643)
7. Trachootham D, Lu W, Ogasawara MA, Del Valle NR, Huang P. Redox regulation in cell survival. Antioxid Redox Signal 2008;10:1343-74.
8. Kroemer G, Pouyssegur J. Tumour cell metabolism: cancer's Achilles' heel. Cancer Cell 2008;13:472-82. (Pubitemid 351766797)
9. Kagan V, Bakalova R, Karakashev P. Lipid peroxidation in the tumour cells and tissues of tumour-bearing animals. In:Vigo-Pelfrey C, editor. Membrane lipid oxidation. Boca Raton (FL): CRC Press; 1992;Volume III:p. 191-208.
10. Gupta SC, Hevia D, Patchva S, Park B, Koh W, Aggrawal BB. Upsides and downsides of ROS for cancer: the roles of ROS in tumourogenesis, prevention, and therapy. Antioxid Redox Signal 2012;16:1295-322.
11. Mandal S, Lindgren AG, Srivastava AS, Clark AT, Banerjee U. Mitochondrial function controls proliferation and early differentiation potential of embryonic stem cells. Stem Cells 2011;29:486-95.
12. Fulda S, Galluzzi L, Kroemer G. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 2010;9:447-64.
13. Kroemer G. Mitochondria in cancer. Oncogene 2006;25:4630-2. (Pubitemid 44187613)
14. Sanchez-Aragó M, Formentini L, Cuezva M. Mitochondria-mediated energy adaptation in cancer: the H(+)-ATP synthase-geared switch of metabolism in human tumors. Antioxid Redox Signal. 2012 Sep 24. [Epub ahead of print].
15. Chan EC, Jiang F, Peshavariya HM, Dusting GJ. Regulation of cell proliferation by NAHDH oxidase-mediated signaling: potential role in tissue repair, regenerative medicine and tissue engineering. Pharmacol Ther 2009;122:97-108.
16. Hayes P, Knaus UG. Balancing reactive oxygen species in the epigenome: NADPH oxidases as target and perpetrator. Antioxid Redox Signal. 2012 Nov 5. [Epub ahead of print].
17. Chaiswing L, Zhong W, Liang Y, Jones DP, Oberley TD. Regulation of prostate cancer cell invasion my modulating of extra- and intracellular redox balance. Free Radic Biol Med 2012;52:452-61.
18. Hamanaka RB, Chandel BS. Mitochondrial reactive oxygen species regulate hypoxic signaling. Curr Opin Cell Biol 2009;21:894-9.
19. Zhelev Z, Bakalova R, Aoki I, Gadjeva V, Kanno I. Imaging of cancer by redox-mediated mechanism: a radical diagnostic approach. Mol BioSyst 2010;6:2386-8.
20. Zhelev Z, Gadjeva V, Aoki I, Bakalova R, Saga T. Cell-penetrating nitroxides as molecular sensors for imaging of cancer in vivo, based on tissue redox activity. Mol BioSyst 2012;8:2733-40.
21. Zhelev Z, Aoki I, Gadjeva V, Nikolova B, Bakalova R, Saga T. Tissue redox activity as a sensing platform for imaging of cancer based on nitroxide redox cycle. Eur J Cancer. 2012 Dec 19. [Epub ahead of print].
22. Matsumoto K, Hyodo F, Matsumoto A, Koretsky AP, Sowers AL, Mitchell JB, et al. High-resolution mapping of tumor redox status by MRI using nitroxides as redox-sensitive contrast agents. Clin Cancer Res 2006;12:2355-62.
23. Hyodo F, Matsumoto K, Matsumoto A, Mitchell JB, Krishna MC. Probing the intracellular redox status of tumors with magnetic resonance imaging and redox-sensitive contrast agents. Cancer Res 2006;66:9921-8. (Pubitemid 44672044)
24. Davis RM, Matsumoto S, Brnardo M, Sowers A, Matsumoto K, Krishna MC, et al. Magnetic resonance imaging of organic contrast agents in mice: capturing the whole-body redox landscape. Free Rad Biol Med 2011;50:459-68.
25. Fuchs J, Groth N, Herrling T, Zimmer G. Electron paramagnetic resonance studies on nitroxide radical 2,2,5,5-tetramethyl-4-piperi-din-1-oxyl (TEMPO) redox reactions in human skin. Free Radic Biol Med 1997;22:967-76. (Pubitemid 27084133)
26. Batinic-Haberle I, Reboucas JS, Spasijevic I. Superoxide dismutase mimetics: chemistry, pharmacology, and therapeutic potential. Antioxid Redox Signal 2010;13:877-918.
27. Mehlhorn RJ. Ascorbate- and dehydroascorbic acid-mediated reduction of free radicals in the human erythrocytes. J Biol Chem 1991;266:2724-31.
28. Bobko AA, Kirilyuk IA, Grigor'ev IA, Zweier JL, Khramtsov VV. Reversible reduction of nitroxides to hydroxylamines: the roles for ascorbate and glutathione. Free Radic Biol Med 2007;42:404-12. (Pubitemid 46038046)
29. Matsumoto A, Matsumoto K, Matsumoto S, Hyodo F, Sowers AL, Koscielniak JW, et al. Intracellular hypoxia of tumor tissue estimated by noninvasive EPR oximetry technique using paramagnetic probes. Biol Pharm Bull 2011;34:142-5.
30. Ui I, Okajo A, Endo K, Utsumi H, Matsumoto K. Effect of hydrogen peroxide in redox status estimation using nitroxyl spin probe. Free Radic Biol Med 2004;37:2012-7. (Pubitemid 39491320)
31. Soule BP, Hyodo F, Matsumoto K, Simone NL, Cook JA, Krishna MC, et al. Therapeutic and clinical applications of nitroxide compounds. Antioxid Redox Signal 2007;9:1731-42.
32. Hyodo F, Soule BP, Matsumoto K, Matsumoto S, Cook JA, Hyodo E, et al. Assessment of tissue redox status using metabolic responsive contrast agents and magnetic resonance imaging. J Pharm Pharmacol 2008;60:1049-60.
33. Hyodo F, Murugesan R, Matsumoto K, Hyodo E, Subramanian S, Mitchell JB, et al. Monitoring redox-sensitive paramagnetic contrast agent by EPRI, OMRI and MRI. J Magn Reson 2008;190:105-12. (Pubitemid 350235256)
34. Rosen GM, Cohen MC, Britigan BE, Pou S. Application of spin traps to biological systems. Free Radic Res Commun 1990;9:187-95. (Pubitemid 20376771)
35. Zhelev Z, Matsumoto K, Gadjeva V, Bakalova R, Aoki I, Zheleva A, et al. EPR signal reduction kinetic of several nitroxyl derivatives in blood in vitro and in vivo. Gen Physiol Biophys 2009;28:356-62.
36. Okajo A, Matsumoto K, Mitchell JB, Krishna MC, Endo K. Competition of nitroxyl contrast agents as an in vivo tissue redox probe: comparison of pharmacokinetics by the bile flow monitoring (BFM) and blood circulating monitoring (BCM) methods using X-band EPR and simulation of decay pro files. Magn Reson Med 2006;56:422-31. (Pubitemid 44162790)
37. Hyodo F, Chuang KH, Goloshevsky AG, Sulima A, Griffiths GL, Mitchell JB, et al. Brain redox imaging using blood-brain barrier-permeable nitroxide MRI contrast agent. J Cereb Blood Flow Metab 2008;28:1165-74. (Pubitemid 351733355)
38. Gadjeva V. Structure-based design of nitrosoureas containing tyrosine derivatives as potential antimelanoma agents. Eur J Med Chem 2002;37:295-7.
39. Zhelev Z, Bakalova R, Aoki I, Matsumoto K, Gadjeva V, Anzai K, et al. Nitroxyl radicals for labeling of conventional therapeutics and noninvasive magnetic resonance imaging of their permeability for blood-brain barrier: relationship between structure, blood clearance, and MRI signal dynamic in the brain. Mol Pharm 2009;6:504-12.
40. Lage H, Dietel M. Involvement of the DNA mismatch repair system in antineoplastic drug resistance. J Cancer Res Clin Oncol 1999;125:156-65. (Pubitemid 29172506)
41. Kundu JK, Surh Y-J. Emerging avenues linking inflammation and cancer. Free Radic Biol Med 2012;52:2013-37.
42. Paez D, Labonte MJ, Bohanes P, Zhang W, Benhanim L, Ning Y, et al. Cancer dormancy: a model of early dissemination and late cancer recurrence. Clin Cancer Res 2011;18:645-53.
43. Gregg D, de Carvalho DD, Kavacic H. Integrins and coagulation: a role for ROS/redox signaling? Antioxid Redox Signal 2004;6:757-64. (Pubitemid 38890793)
44. Rutnam ZJ, Wight TN, Yang BB. miRNAs regulate expression and function of extracellular matrix molecules. Matrix Biol. 2012 Nov 15. [Epub ahead of print].
45. Dalmay T, Edwards DR. MicroRNAs and the hallmarks of cancer. Oncogene 2006;25:6170-5. (Pubitemid 44527847)
46. Svineng G, Ravuri C, Rikardsen O, Huseby NE, Winberg JO. The role of reactive oxygen species in integrin and matrix metalloproteinase expression and function. Connect Tissue Res 2008;49:197-202.